United States · FDA National Drug Code directory
INVEGA HAFYERA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50458-611_2e6ef0e1-19d2-7d78-e063-6394a90ae8a6
- Product NDC
- 50458-611
- Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Composition / generic term
- paliperidone palmitate
- Labeler
- Janssen Pharmaceuticals, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210830
- Source listing expiry
- 20261231
Source-listed ingredients
- PALIPERIDONE PALMITATE — 1092 mg/3.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (50458-611-01) / 3.5 mL in 1 SYRINGE · 50458-611-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →